DGF

Clinical trials for DGF explained in plain language.

Never miss a new study

Get alerted when new DGF trials appear

Sign up with your email to follow new studies for DGF, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2

New drug aims to cut dialysis time after kidney transplant

Disease control Recruiting now

This study tests if the drug ravulizumab can help transplanted kidneys start working sooner, reducing the need for dialysis. It involves 450 adults at high risk for delayed graft function after receiving a deceased donor kidney. Participants will receive either ravulizumab or a p…

Matched conditions: DGF

Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated May 11, 2026 20:38 UTC

DGF

Get alerted when new DGF trials appear

New drug aims to cut dialysis time after kidney transplant